dr. george demetri describes the mechanism of action of regorafenib in gist
Published 11 years ago • 1.1K plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
1:21
dr. george demetri explains the side effects associated with regorafenib
-
1:23
dr. george demetri discusses regorafenib for patients with gist trial results
-
9:39
george d. demetri: grid trial
-
10:02
role of the multikinase inhibitor regorafenib in metastatic colorectal cancer
-
11:24
managing toxicities associated with regorafenib
-
7:41
regorafenib in management of colorectal cancer – video abstract [id 88825]
-
4:17
what is gastrointestinal stromal tumor (gist)
-
58:19
leading edge medicine with dr. sumanth prabhu
-
9:11
state of the art of fusion imaging in prostatic applications - prof. giancarlo bizzarri
-
0:42
dr. keedy on regorafenib for the treatment of gist
-
5:31
practical advice for using regorafenib
-
3:08
gastrointestinal stromal tumor (gist) of the stomach
-
1:02
regorafenib as a treatment for gist (gastrointestinal stromal tumour) patients
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
12:53
gist 2010 - dr. george demetri
-
9:34
regorafenib in colorectal cancer
-
6:15
adjuvant treatment in gastrointestinal stromal tumor (gist)
-
1:29
dr. demetri on larotrectinib in trk-fusion gi cancers
-
2:03
dr. axel grothey on the side effect profile of regorafenib in metastatic colorectal cancer
-
4:20
robotic excision of difficult to access gastric gists
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
1:47
dr. axel grothey on the time course of regorafenib-associated adverse events